Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer

Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer

Abstract Introduction It is unclear how soon after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection it is safe to resume systemic anti-neoplastic treatment in patients with cancer. We assessed the risk of admissions or postponed treatment cycle in vaccinated patients with breas...

Full description

Bibliographic Details
Main Authors: Naama Halpern, Ben Boursi, Einat Shacham-Shmueli, Einav Nili Gal-Yam, Ofer Margalit, Talia Golan, Tamar Beller, Gal Strauss, Dafna Yahav, Eyal Leshem
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Oncology and Therapy
Subjects:
COVID-19
SARS-CoV-2
Breast cancer
Chemotherapy
Oncology
Online Access:https://doi.org/10.1007/s40487-023-00247-2

Internet

https://doi.org/10.1007/s40487-023-00247-2

Similar Items